10 20 30 40 50 60 70 80 1KWM - Header ----|----|----|----|----|----|----|----|----|----|----|----|----|----|----|----| Asymmetric UnitHEADER HYDROLASE 30-JAN-02 1KWM
TITLE HUMAN PROCARBOXYPEPTIDASE B: THREE-DIMENSIONAL STRUCTURE TITLE 2 AND IMPLICATIONS FOR THROMBIN-ACTIVATABLE FIBRINOLYSIS TITLE 3 INHIBITOR (TAFI)
COMPND MOL_ID: 1; COMPND 2 MOLECULE: PROCARBOXYPEPTIDASE B; COMPND 3 CHAIN: A, B; COMPND 4 EC: 3.4.17.2; COMPND 5 ENGINEERED: YES
SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: PICHIA PASTORIS; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 4922; SOURCE 7 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 8 EXPRESSION_SYSTEM_PLASMID: PPIC9
KEYWDS HYDROLASE, PROCARBOXYPEPTIDASE B
EXPDTA X-RAY DIFFRACTION
AUTHOR P.J.B.PEREIRA,S.SEGURA-MARTIN,C.FERRER-ORTA,J.VENDRELL,F.- AUTHOR 2 X.AVILES,M.COLL,F.-X.GOMIS-RUETH
REVDAT 4 24-FEB-09 1KWM 1 VERSN REVDAT 3 01-APR-03 1KWM 1 JRNL REVDAT 2 28-AUG-02 1KWM 1 JRNL REVDAT 1 05-JUN-02 1KWM 0
JRNL AUTH P.J.BARBOSA PEREIRA,S.SEGURA-MARTIN,B.OLIVA, JRNL AUTH 2 C.FERRER-ORTA,F.X.AVILES,M.COLL,F.X.GOMIS-RUTH, JRNL AUTH 3 J.VENDRELL JRNL TITL HUMAN PROCARBOXYPEPTIDASE B: THREE-DIMENSIONAL JRNL TITL 2 STRUCTURE AND IMPLICATIONS FOR JRNL TITL 3 THROMBIN-ACTIVATABLE FIBRINOLYSIS INHIBITOR (TAFI). JRNL REF J.MOL.BIOL. V. 321 537 2002 JRNL REFN ISSN 0022-2836 JRNL PMID 12162965 JRNL DOI 10.1016/S0022-2836(02)00648-4
REMARK 1
REMARK 2 REMARK 2 RESOLUTION. 1.60 ANGSTROMS.
REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : SHELXL-97 REMARK 3 AUTHORS : G.M.SHELDRICK REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.60 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 27.40 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : NULL REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (NO CUTOFF). REMARK 3 R VALUE (WORKING + TEST SET, NO CUTOFF) : 0.136 REMARK 3 R VALUE (WORKING SET, NO CUTOFF) : 0.136 REMARK 3 FREE R VALUE (NO CUTOFF) : 0.185 REMARK 3 FREE R VALUE TEST SET SIZE (%, NO CUTOFF) : NULL REMARK 3 FREE R VALUE TEST SET COUNT (NO CUTOFF) : 5241 REMARK 3 TOTAL NUMBER OF REFLECTIONS (NO CUTOFF) : 104785 REMARK 3 REMARK 3 FIT/AGREEMENT OF MODEL FOR DATA WITH F>4SIG(F). REMARK 3 R VALUE (WORKING + TEST SET, F>4SIG(F)) : NULL REMARK 3 R VALUE (WORKING SET, F>4SIG(F)) : NULL REMARK 3 FREE R VALUE (F>4SIG(F)) : NULL REMARK 3 FREE R VALUE TEST SET SIZE (%, F>4SIG(F)) : NULL REMARK 3 FREE R VALUE TEST SET COUNT (F>4SIG(F)) : NULL REMARK 3 TOTAL NUMBER OF REFLECTIONS (F>4SIG(F)) : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 6578 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 15 REMARK 3 SOLVENT ATOMS : 814 REMARK 3 REMARK 3 MODEL REFINEMENT. REMARK 3 OCCUPANCY SUM OF NON-HYDROGEN ATOMS : NULL REMARK 3 OCCUPANCY SUM OF HYDROGEN ATOMS : NULL REMARK 3 NUMBER OF DISCRETELY DISORDERED RESIDUES : NULL REMARK 3 NUMBER OF LEAST-SQUARES PARAMETERS : NULL REMARK 3 NUMBER OF RESTRAINTS : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM RESTRAINT TARGET VALUES. REMARK 3 BOND LENGTHS (A) : NULL REMARK 3 ANGLE DISTANCES (A) : NULL REMARK 3 SIMILAR DISTANCES (NO TARGET VALUES) (A) : NULL REMARK 3 DISTANCES FROM RESTRAINT PLANES (A) : NULL REMARK 3 ZERO CHIRAL VOLUMES (A**3) : NULL REMARK 3 NON-ZERO CHIRAL VOLUMES (A**3) : NULL REMARK 3 ANTI-BUMPING DISTANCE RESTRAINTS (A) : NULL REMARK 3 RIGID-BOND ADP COMPONENTS (A**2) : NULL REMARK 3 SIMILAR ADP COMPONENTS (A**2) : NULL REMARK 3 APPROXIMATELY ISOTROPIC ADPS (A**2) : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED: NULL REMARK 3 REMARK 3 STEREOCHEMISTRY TARGET VALUES : ENGH & HUBER REMARK 3 SPECIAL CASE: NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL
REMARK 4 REMARK 4 1KWM COMPLIES WITH FORMAT V. 3.15, 01-DEC-08
REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 31-JAN-02. REMARK 100 THE RCSB ID CODE IS RCSB015412.
REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 15-DEC-99 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : EMBL/DESY, HAMBURG REMARK 200 BEAMLINE : BW7A REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.97935 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : MARRESEARCH REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : CCP4 (SCALA) REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 104805 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.600 REMARK 200 RESOLUTION RANGE LOW (A) : 27.400 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 89.7 REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 0.05000 REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 8.4000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.60 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.68 REMARK 200 COMPLETENESS FOR SHELL (%) : 81.9 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : 0.24100 REMARK 200 <I/SIGMA(I)> FOR SHELL : 2.700 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: AMORE REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL
REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 49.93 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.46 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: MES, SODIUM CITRATE, SODIUM REMARK 280 CHLORIDE, PH 6.0, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE REMARK 280 293K
REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 41.77900 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL
REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA.
REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000
REMARK 475 REMARK 475 ZERO OCCUPANCY RESIDUES REMARK 475 THE FOLLOWING RESIDUES WERE MODELED WITH ZERO OCCUPANCY. REMARK 475 THE LOCATION AND PROPERTIES OF THESE RESIDUES MAY NOT REMARK 475 BE RELIABLE. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 475 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE) REMARK 475 M RES C SSEQI REMARK 475 ARG A 95A REMARK 475 SER B 92A REMARK 475 ARG B 93A REMARK 475 VAL B 94A
REMARK 480 REMARK 480 ZERO OCCUPANCY ATOM REMARK 480 THE FOLLOWING RESIDUES HAVE ATOMS MODELED WITH ZERO REMARK 480 OCCUPANCY. THE LOCATION AND PROPERTIES OF THESE ATOMS REMARK 480 MAY NOT BE RELIABLE. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 480 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 480 M RES C SSEQI ATOMS REMARK 480 GLU A 5A CG CD OE1 OE2 REMARK 480 HIS A 6A CG ND1 CD2 CE1 NE2 REMARK 480 GLN A 34A CG CD OE1 NE2 REMARK 480 LYS A 47A CD CE NZ REMARK 480 LYS A 57A CE NZ REMARK 480 GLU A 59A CD OE1 OE2 REMARK 480 GLN A 70A CG CD OE1 NE2 REMARK 480 ARG A 93A CD NE CZ NH1 NH2 REMARK 480 GLN A 57 CD OE1 NE2 REMARK 480 GLU A 98 CD OE1 OE2 REMARK 480 LYS A 102 NZ REMARK 480 GLU A 214 CG CD OE1 OE2 REMARK 480 GLU B 5A CB CG CD OE1 OE2 REMARK 480 GLU B 28A CB CG CD OE1 OE2 REMARK 480 LYS B 57A CD CE NZ REMARK 480 GLU B 59A CG CD OE1 OE2 REMARK 480 LYS B 69A CE NZ REMARK 480 GLN B 70A CG CD OE1 NE2 REMARK 480 GLU B 72A CG CD OE1 OE2 REMARK 480 ARG B 83A NE CZ NH1 NH2 REMARK 480 LYS B 11 CE NZ REMARK 480 GLN B 57 CD OE1 NE2 REMARK 480 LYS B 102 CE NZ REMARK 480 LYS B 122 CD CE NZ
REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O PHE B 90A OG SER B 92A 0.92 REMARK 500 OE2 GLU A 59A O HOH A 1082 1.62 REMARK 500 C PHE B 90A OG SER B 92A 1.95 REMARK 500 O ASN A 66A CG GLN A 70A 1.97 REMARK 500 C SER B 92A O HOH B 583 2.00 REMARK 500 N ARG B 93A O HOH B 583 2.08 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 TYR A 248 CB - CG - CD1 ANGL. DEV. = 4.7 DEGREES REMARK 500 TYR B 208 CB - CG - CD1 ANGL. DEV. = 4.2 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 PRO A 40A -173.16 -69.89 REMARK 500 ALA A 4 163.06 171.92 REMARK 500 LYS A 122 -35.62 -134.11 REMARK 500 ARG A 127 -30.66 -131.07 REMARK 500 SER A 199 -4.32 138.48 REMARK 500 GLN A 200 66.19 64.63 REMARK 500 ILE A 247 -88.18 -112.99 REMARK 500 ASP A 273 -144.54 -108.26 REMARK 500 PRO B 40A -173.75 -68.10 REMARK 500 ASP B 91A 67.31 -116.52 REMARK 500 SER B 92A -176.08 172.90 REMARK 500 ARG B 93A -44.25 -169.53 REMARK 500 VAL B 94A -73.62 93.73 REMARK 500 LYS B 122 -39.66 -133.01 REMARK 500 THR B 129 -172.02 -66.36 REMARK 500 CYS B 152 15.10 56.12 REMARK 500 SER B 199 -4.34 134.41 REMARK 500 GLN B 200 65.17 63.51 REMARK 500 ILE B 247 -85.95 -113.59 REMARK 500 ASP B 273 -145.21 -105.88 REMARK 500 REMARK 500 REMARK: NULL
REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH A1320 DISTANCE = 5.06 ANGSTROMS
REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 ZN A 400 ZN REMARK 620 N RES CSSEQI ATOM REMARK 620 1 HIS A 69 ND1 REMARK 620 2 GLU A 72 OE1 123.0 REMARK 620 3 GLU A 72 OE2 96.5 53.5 REMARK 620 4 HIS A 196 ND1 104.0 98.6 151.8 REMARK 620 5 HOH A1352 O 119.5 110.7 94.0 92.6 REMARK 620 N 1 2 3 4 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 ZN B 400 ZN REMARK 620 N RES CSSEQI ATOM REMARK 620 1 GLU B 72 OE1 REMARK 620 2 GLU B 72 OE2 53.9 REMARK 620 3 HIS B 69 ND1 122.7 95.2 REMARK 620 4 HIS B 196 ND1 101.1 154.7 96.5 REMARK 620 5 HOH B 761 O 95.6 81.9 130.1 106.9 REMARK 620 N 1 2 3 4
REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ZN A 400 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ZN B 400 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CIT A 900
DBREF 1KWM A 1A 309 UNP P15086 CBPB1_HUMAN 16 417 DBREF 1KWM B 1A 309 UNP P15086 CBPB1_HUMAN 16 417
SEQRES 1 A 402 HIS HIS GLY GLY GLU HIS PHE GLU GLY GLU LYS VAL PHE SEQRES 2 A 402 ARG VAL ASN VAL GLU ASP GLU ASN HIS ILE ASN ILE ILE SEQRES 3 A 402 ARG GLU LEU ALA SER THR THR GLN ILE ASP PHE TRP LYS SEQRES 4 A 402 PRO ASP SER VAL THR GLN ILE LYS PRO HIS SER THR VAL SEQRES 5 A 402 ASP PHE ARG VAL LYS ALA GLU ASP THR VAL THR VAL GLU SEQRES 6 A 402 ASN VAL LEU LYS GLN ASN GLU LEU GLN TYR LYS VAL LEU SEQRES 7 A 402 ILE SER ASN LEU ARG ASN VAL VAL GLU ALA GLN PHE ASP SEQRES 8 A 402 SER ARG VAL ARG ALA THR GLY HIS SER TYR GLU LYS TYR SEQRES 9 A 402 ASN LYS TRP GLU THR ILE GLU ALA TRP THR GLN GLN VAL SEQRES 10 A 402 ALA THR GLU ASN PRO ALA LEU ILE SER ARG SER VAL ILE SEQRES 11 A 402 GLY THR THR PHE GLU GLY ARG ALA ILE TYR LEU LEU LYS SEQRES 12 A 402 VAL GLY LYS ALA GLY GLN ASN LYS PRO ALA ILE PHE MET SEQRES 13 A 402 ASP CYS GLY PHE HIS ALA ARG GLU TRP ILE SER PRO ALA SEQRES 14 A 402 PHE CYS GLN TRP PHE VAL ARG GLU ALA VAL ARG THR TYR SEQRES 15 A 402 GLY ARG GLU ILE GLN VAL THR GLU LEU LEU ASN LYS LEU SEQRES 16 A 402 ASP PHE TYR VAL LEU PRO VAL LEU ASN ILE ASP GLY TYR SEQRES 17 A 402 ILE TYR THR TRP THR LYS SER ARG PHE TRP ARG LYS THR SEQRES 18 A 402 ARG SER THR HIS THR GLY SER SER CYS ILE GLY THR ASP SEQRES 19 A 402 PRO ASN ARG ASN PHE ASP ALA GLY TRP CYS GLU ILE GLY SEQRES 20 A 402 ALA SER ARG ASN PRO CYS ASP GLU THR TYR CYS GLY PRO SEQRES 21 A 402 ALA ALA GLU SER GLU LYS GLU THR LYS ALA LEU ALA ASP SEQRES 22 A 402 PHE ILE ARG ASN LYS LEU SER SER ILE LYS ALA TYR LEU SEQRES 23 A 402 THR ILE HIS SER TYR SER GLN MET MET ILE TYR PRO TYR SEQRES 24 A 402 SER TYR ALA TYR LYS LEU GLY GLU ASN ASN ALA GLU LEU SEQRES 25 A 402 ASN ALA LEU ALA LYS ALA THR VAL LYS GLU LEU ALA SER SEQRES 26 A 402 LEU HIS GLY THR LYS TYR THR TYR GLY PRO GLY ALA THR SEQRES 27 A 402 THR ILE TYR PRO ALA ALA GLY GLY SER ASP ASP TRP ALA SEQRES 28 A 402 TYR ASP GLN GLY ILE ARG TYR SER PHE THR PHE GLU LEU SEQRES 29 A 402 ARG ASP THR GLY ARG TYR GLY PHE LEU LEU PRO GLU SER SEQRES 30 A 402 GLN ILE ARG ALA THR CYS GLU GLU THR PHE LEU ALA ILE SEQRES 31 A 402 LYS TYR VAL ALA SER TYR VAL LEU GLU HIS LEU TYR SEQRES 1 B 402 HIS HIS GLY GLY GLU HIS PHE GLU GLY GLU LYS VAL PHE SEQRES 2 B 402 ARG VAL ASN VAL GLU ASP GLU ASN HIS ILE ASN ILE ILE SEQRES 3 B 402 ARG GLU LEU ALA SER THR THR GLN ILE ASP PHE TRP LYS SEQRES 4 B 402 PRO ASP SER VAL THR GLN ILE LYS PRO HIS SER THR VAL SEQRES 5 B 402 ASP PHE ARG VAL LYS ALA GLU ASP THR VAL THR VAL GLU SEQRES 6 B 402 ASN VAL LEU LYS GLN ASN GLU LEU GLN TYR LYS VAL LEU SEQRES 7 B 402 ILE SER ASN LEU ARG ASN VAL VAL GLU ALA GLN PHE ASP SEQRES 8 B 402 SER ARG VAL ARG ALA THR GLY HIS SER TYR GLU LYS TYR SEQRES 9 B 402 ASN LYS TRP GLU THR ILE GLU ALA TRP THR GLN GLN VAL SEQRES 10 B 402 ALA THR GLU ASN PRO ALA LEU ILE SER ARG SER VAL ILE SEQRES 11 B 402 GLY THR THR PHE GLU GLY ARG ALA ILE TYR LEU LEU LYS SEQRES 12 B 402 VAL GLY LYS ALA GLY GLN ASN LYS PRO ALA ILE PHE MET SEQRES 13 B 402 ASP CYS GLY PHE HIS ALA ARG GLU TRP ILE SER PRO ALA SEQRES 14 B 402 PHE CYS GLN TRP PHE VAL ARG GLU ALA VAL ARG THR TYR SEQRES 15 B 402 GLY ARG GLU ILE GLN VAL THR GLU LEU LEU ASN LYS LEU SEQRES 16 B 402 ASP PHE TYR VAL LEU PRO VAL LEU ASN ILE ASP GLY TYR SEQRES 17 B 402 ILE TYR THR TRP THR LYS SER ARG PHE TRP ARG LYS THR SEQRES 18 B 402 ARG SER THR HIS THR GLY SER SER CYS ILE GLY THR ASP SEQRES 19 B 402 PRO ASN ARG ASN PHE ASP ALA GLY TRP CYS GLU ILE GLY SEQRES 20 B 402 ALA SER ARG ASN PRO CYS ASP GLU THR TYR CYS GLY PRO SEQRES 21 B 402 ALA ALA GLU SER GLU LYS GLU THR LYS ALA LEU ALA ASP SEQRES 22 B 402 PHE ILE ARG ASN LYS LEU SER SER ILE LYS ALA TYR LEU SEQRES 23 B 402 THR ILE HIS SER TYR SER GLN MET MET ILE TYR PRO TYR SEQRES 24 B 402 SER TYR ALA TYR LYS LEU GLY GLU ASN ASN ALA GLU LEU SEQRES 25 B 402 ASN ALA LEU ALA LYS ALA THR VAL LYS GLU LEU ALA SER SEQRES 26 B 402 LEU HIS GLY THR LYS TYR THR TYR GLY PRO GLY ALA THR SEQRES 27 B 402 THR ILE TYR PRO ALA ALA GLY GLY SER ASP ASP TRP ALA SEQRES 28 B 402 TYR ASP GLN GLY ILE ARG TYR SER PHE THR PHE GLU LEU SEQRES 29 B 402 ARG ASP THR GLY ARG TYR GLY PHE LEU LEU PRO GLU SER SEQRES 30 B 402 GLN ILE ARG ALA THR CYS GLU GLU THR PHE LEU ALA ILE SEQRES 31 B 402 LYS TYR VAL ALA SER TYR VAL LEU GLU HIS LEU TYR
HET ZN A 400 1 HET ZN B 400 1 HET CIT A 900 13
HETNAM ZN ZINC ION HETNAM CIT CITRIC ACID
FORMUL 3 ZN 2(ZN 2+) FORMUL 5 CIT C6 H8 O7 FORMUL 6 HOH *814(H2 O)
HELIX 1 1 GLY A 3A GLU A 8A 5 6 HELIX 2 2 ASP A 19A THR A 33A 1 15 HELIX 3 3 SER A 42A ILE A 46A 5 5 HELIX 4 4 ASP A 60A ASN A 71A 1 12 HELIX 5 5 ASN A 81A GLN A 89A 1 9 HELIX 6 6 LYS A 14 ASN A 29 1 16 HELIX 7 7 TRP A 73 TYR A 90 1 18 HELIX 8 8 GLU A 93 LEU A 103 1 11 HELIX 9 9 ASN A 112 LYS A 122 1 11 HELIX 10 10 ASP A 142 ASN A 146 5 5 HELIX 11 11 GLU A 173 LYS A 186 1 14 HELIX 12 12 ASN A 215 GLY A 235 1 21 HELIX 13 13 GLY A 243 ILE A 247 1 5 HELIX 14 14 GLY A 253 GLN A 261 1 9 HELIX 15 15 TYR A 277 LEU A 281 5 5 HELIX 16 16 PRO A 282 SER A 284 5 3 HELIX 17 17 GLN A 285 GLU A 306 1 22 HELIX 18 18 GLY B 3A GLU B 8A 5 6 HELIX 19 19 ASP B 19A THR B 33A 1 15 HELIX 20 20 SER B 42A ILE B 46A 5 5 HELIX 21 21 ASP B 60A ASN B 71A 1 12 HELIX 22 22 ASN B 81A GLN B 89A 1 9 HELIX 23 23 LYS B 14 ASN B 29 1 16 HELIX 24 24 TRP B 73 TYR B 90 1 18 HELIX 25 25 GLU B 93 LEU B 103 1 11 HELIX 26 26 ASN B 112 LYS B 122 1 11 HELIX 27 27 ASP B 142 ASN B 146 5 5 HELIX 28 28 GLU B 173 LYS B 186 1 14 HELIX 29 29 ASN B 215 GLY B 235 1 21 HELIX 30 30 GLY B 243 ILE B 247 1 5 HELIX 31 31 GLY B 253 GLN B 261 1 9 HELIX 32 32 TYR B 277 LEU B 281 5 5 HELIX 33 33 PRO B 282 SER B 284 5 3 HELIX 34 34 GLN B 285 GLU B 306 1 22
SHEET 1 B 8 ILE A 33 THR A 40 0 SHEET 2 B 8 ALA A 46 VAL A 52 -1 O LYS A 51 N SER A 34 SHEET 3 B 8 ASP A 104 LEU A 108 -1 O PHE A 105 N VAL A 52 SHEET 4 B 8 ALA A 61 ASP A 65 1 N MET A 64 O TYR A 106 SHEET 5 B 8 ILE A 189 HIS A 196 1 O LYS A 190 N ALA A 61 SHEET 6 B 8 TYR A 265 GLU A 270 1 O PHE A 269 N HIS A 196 SHEET 7 B 8 MET A 201 TYR A 204 -1 N MET A 201 O GLU A 270 SHEET 8 B 8 THR A 239 PRO A 242 1 O THR A 239 N MET A 202 SHEET 1 D 8 ILE B 33 THR B 40 0 SHEET 2 D 8 ALA B 46 VAL B 52 -1 O LYS B 51 N SER B 34 SHEET 3 D 8 ASP B 104 LEU B 108 -1 O PHE B 105 N VAL B 52 SHEET 4 D 8 ALA B 61 ASP B 65 1 N MET B 64 O TYR B 106 SHEET 5 D 8 ILE B 189 HIS B 196 1 O LYS B 190 N ALA B 61 SHEET 6 D 8 TYR B 265 GLU B 270 1 O PHE B 269 N HIS B 196 SHEET 7 D 8 MET B 201 TYR B 204 -1 N ILE B 203 O THR B 268 SHEET 8 D 8 THR B 239 PRO B 242 1 O THR B 239 N MET B 202
SSBOND 1 CYS A 66 CYS A 79 1555 1555 2.02 SSBOND 2 CYS A 138 CYS A 161 1555 1555 2.00 SSBOND 3 CYS A 152 CYS A 166 1555 1555 2.05 SSBOND 4 CYS B 66 CYS B 79 1555 1555 2.02 SSBOND 5 CYS B 138 CYS B 161 1555 1555 2.02 SSBOND 6 CYS B 152 CYS B 166 1555 1555 2.05
LINK ZN ZN A 400 ND1AHIS A 69 1555 1555 2.03 LINK ZN ZN A 400 OE1 GLU A 72 1555 1555 2.31 LINK ZN ZN A 400 OE2 GLU A 72 1555 1555 2.53 LINK ZN ZN A 400 ND1 HIS A 196 1555 1555 2.29 LINK ZN ZN A 400 O HOH A1352 1555 1555 2.44 LINK ZN ZN B 400 OE1 GLU B 72 1555 1555 2.29 LINK ZN ZN B 400 OE2 GLU B 72 1555 1555 2.54 LINK ZN ZN B 400 ND1AHIS B 69 1555 1555 2.11 LINK ZN ZN B 400 ND1 HIS B 196 1555 1555 2.33 LINK ZN ZN B 400 O HOH B 761 1555 1555 2.61
CISPEP 1 LYS A 39A PRO A 40A 0 -2.30 CISPEP 2 SER A 197 TYR A 198 0 -14.07 CISPEP 3 PRO A 205 TYR A 206 0 5.95 CISPEP 4 ARG A 272 ASP A 273 0 -1.26 CISPEP 5 LYS B 39A PRO B 40A 0 -12.51 CISPEP 6 ASP B 91A SER B 92A 0 0.04 CISPEP 7 SER B 197 TYR B 198 0 -13.04 CISPEP 8 PRO B 205 TYR B 206 0 4.27 CISPEP 9 ARG B 272 ASP B 273 0 -5.40
SITE 1 AC1 5 HIS A 69 GLU A 72 ASN A 144 HIS A 196 SITE 2 AC1 5 HOH A1352 SITE 1 AC2 5 HIS B 69 GLU B 72 ASN B 144 HIS B 196 SITE 2 AC2 5 HOH B 761 SITE 1 AC3 13 LEU A 78A HIS A 133 GLY A 135 SER A 136 SITE 2 AC3 13 TYR A 165 PRO A 168 ARG A 276 HOH A 967 SITE 3 AC3 13 HOH A 990 HOH A1121 HOH A1174 HOH A1185 SITE 4 AC3 13 HOH A1197
CRYST1 42.959 83.558 127.447 90.00 99.12 90.00 P 1 21 1 4
ORIGX1 1.000000 0.000000 0.000000 0.00000
ORIGX2 0.000000 1.000000 0.000000 0.00000
ORIGX3 0.000000 0.000000 1.000000 0.00000
SCALE1 0.023278 0.000000 0.003737 0.00000
SCALE2 0.000000 0.011968 0.000000 0.00000
SCALE3 0.000000 0.000000 0.007947 0.00000